Expression of Aryl Hydrocarbon Receptor Nuclear Translocator Enhances Cisplatin Resistance by Upregulating MDR1 Expression in Cancer Cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Pharmacology

• Publication date

  2013-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.113.087197PMID 23907215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells

  2013cited by this paper
• Evolutionary Conserved Regulation of HIF-1β by NF-κB

  2011cited by this paper
• Role of epidermal growth factor receptor degradation in cisplatin-induced cytotoxicity in head and neck cancer.

  2010influential reference
• FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

  2010cited by this paper
• FOXM 1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

  2010cited by this paper
• Involvement of aryl hydrocarbon receptor nuclear translocator in EGF-induced c-Jun/Sp1-mediated gene expression

  2010cited by this paper
• Aryl hydrocarbon nuclear translocator (hypoxia inducible factor 1β) activity is required more during early than late tumor growth

  2010cited by this paper
• A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

  2010cited by this paper
• Epidermal Growth Factor-activated Aryl Hydrocarbon Receptor Nuclear Translocator/HIF-1β Signal Pathway Up-regulates Cyclooxygenase-2 Gene Expression Associated with Squamous Cell Carcinoma*

  2009cited by this paper
• Histone Deacetylase Inhibitor Induction of P-Glycoprotein Transcription Requires Both Histone Deacetylase 1 Dissociation and Recruitment of CAAT/Enhancer Binding Protein β and pCAF to the Promoter Region

  2009cited by this paper
• Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1

  2008cited by this paper
• Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression

  2008influential reference
• PO2-dependent Differential Regulation of Multidrug Resistance 1 Gene Expression by the c-Jun NH2-terminal Kinase Pathway*

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Mechanisms of resistance to cisplatin and carboplatin.

  2007cited by this paper
• BRCA1 Modulates Xenobiotic Stress-inducible Gene Expression by Interacting with ARNT in Human Breast Cancer Cells*

  2006cited by this paper
• HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature.

  2006cited by this paper
• Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.

  2006cited by this paper
• Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel

  2006cited by this paper
• Inactivation of the Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Suppresses von Hippel-Lindau Disease-Associated Vascular Tumors in Mice

  2005influential reference
• Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs

  2005cited by this paper
• HER2-targeting Antibodies Modulate the Cyclin-dependent Kinase Inhibitor p27Kip1 via Multiple Signaling Pathways

  2005influential reference
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

  2005cited by this paper
• Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

  2004cited by this paper
• The mammalian basic helix-loop-helix/PAS family of transcriptional regulators.

  2004cited by this paper
• c-Jun NH2-Terminal Kinase Activation Contributes to Hypoxia-Inducible Factor 1α–Dependent P-Glycoprotein Expression in Hypoxia

  2004cited by this paper
• BRCA1 gene in breast cancer

  2003cited by this paper
• The role of ABC transporters in clinical practice.

  2003cited by this paper
• Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

  2003cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species

  2003cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation

  2002cited by this paper
• Dephosphorylated hypoxia-inducible factor 1α as a mediator of p53-dependent apoptosis during hypoxia

  2001cited by this paper
• Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.

  2001cited by this paper
• Predicting drug sensitivity

  2001cited by this paper
• The PAS superfamily: sensors of environmental and developmental signals.

  2000cited by this paper
• Cisplatin resistance and oncogenes - a review

  2000cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

  1999cited by this paper
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• ARNT-deficient mice and placental differentiation.

  1997cited by this paper
• A point mutation responsible for defective function of the aryl-hydrocarbon-receptor nuclear translocator in mutant Hepa-1c1c7 cells.

  1997cited by this paper
• Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

  1995cited by this paper

• A genome-wide association study using HapMap cell lines reveals modulators of cellular response to cyclophosphamide.

  2025cites this paper
• Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer

  2023cites this paper
• Aryl hydrocarbon receptor nuclear translocator limits the recruitment and function of regulatory neutrophils against colorectal cancer by regulating the gut microbiota

  2023cites this paper
• Alternative Splicing of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Is Regulated by RBFOX2 in Lymphoid Malignancies

  2022cites this paper
• Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer

  2022cites this paper
• ARNT deficiency represses pyruvate dehydrogenase kinase 1 to trigger ROS production and melanoma metastasis

  2021cites this paper
• Sclareol Inhibits Hypoxia-Inducible Factor-1α Accumulation and Induces Apoptosis in Hypoxic Cancer Cells

  2021cites this paper
• Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats.

  2020cites this paper
• Epigenetic Regulation of MDR1 and BCRP Transporters by HDAC Inhibition.

  2020cites this paper
• Epigenetic Regulation of MDR1 and BCRP Transporters by HDAC Inhibition

  2020cites this paper
• Efflux transporters in cancer resistance: Molecular and functional characterization of P-glycoprotein

  2020cites this paper
• Bile duct obstruction leads to increased intestinal expression of breast cancer resistance protein with reduced gastrointestinal absorption of imatinib.

  2019cites this paper
• A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism

  2019cites this paper
• Increased MDR1 Transporter Expression in Human Brain Endothelial Cells Through Enhanced Histone Acetylation and Activation of Aryl Hydrocarbon Receptor Signaling

  2019cites this paper
• Apoptin‐derived peptide reverses cisplatin resistance in gastric cancer through the PI3K–AKT signaling pathway

  2018cites this paper
• HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease.

  2018influential citation
• Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones

  2017cites this paper
• Hypoxic Upregulation of ARNT (HIF-1β): A Cell-Specific Attribute with Clinical Implications

  2017cites this paper
• Identification of ARNT-regulated BIRC3 as the target factor in cadmium renal toxicity

  2017cites this paper
• Investigating a novel small molecule inhibitor of nuclear import as an anti-cancer approach

  2016cites this paper
• Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.

  2016cites this paper
• Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity

  2016cites this paper
• Influence of Renal ABC and SLC Transporter Polymorphisms on Cisplatin-induced Nephrotoxicity in Patients with Esophageal Cancer

  2016cites this paper
• Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.

  2016cites this paper
• The Role of Ahr in Anticancer Drug Resistance in Breast Cancer

  2015cites this paper
• Resistance to Targeted ABC Transporters in Cancer

  2015cites this paper
• The Role of ABC Multidrug Transporters in Resistance to Targeted Anticancer Kinase Inhibitors

  2015cites this paper
• Hypoxia inducible factor 1α down regulates cell surface expression of α1,2‐fucosylated glycans in human pancreatic adenocarcinoma cells

  2015cites this paper
• Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis

  2015cites this paper
• Hypoxia-Inducible Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) (HIF-1β): Is It a Rare Exception?

  2014cites this paper
• An Increase in Reactive Oxygen Species by Deregulation of ARNT Enhances Chemotherapeutic Drug-Induced Cancer Cell Death

  2014cites this paper
• Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.

  2014cites this paper